Organoid and artificial intelligence in breast cancer research
Introduction Organoid and artificial intelligence approaches are central to the FDA’s roadmap for reducing animal use
Organ on Chip
Adipose tissue and breast cancer: decoding proximal crosstalk in 3D model
Introduction Adipose tissue-breast cancer crosstalk is emerging as a key driver of tumor initiation, progression, and
3D Breast Cancer Microenvironment: From Organoids to Organ‑on‑Chip for Understanding the TME
Introduction Following our articles on how breast cancer organoids and breast‑cancer‑on‑chip platforms expand beyond conventional 2D and
2D vs 3D breast cancer models: Patient‑derived organoids for tumor modeling
3D breast cancer models are rapidly redefining how we investigate the world’s deadliest malignancy in women,
Breast cancer organoid: A short history of innovation in breast cancer treatment
Breast cancer has long been one of the most prevalent and challenging cancers worldwide, demanding constant
Breast cancer organoids as alternative to animal models
Breast cancer remains the most frequently diagnosed malignancy in women worldwide and a leading cause of
Adipose Tissue-on-Chip: Perfused Platforms Driving Next-Gen Metabolic Research
Obesity, type 2 diabetes, and non-alcoholic fatty liver disease (NAFLD) remain major global health concerns, yet
Adipose Tissue Organoids: Protocols, Applications & Current Limitations
Adipose tissue organoid technology is reshaping metabolic research. From scaffold-free spheroids to hydrogel-based 3D adipose tissue
Understanding Adipose Tissue: A Key to Drug Discovery in Metabolic Disorders
What Does Adipose Tissue Do? Adipose tissue is more than a fat storage site, it’s a
Brown vs White Adipose Tissue: What is at Stake for Pharma
As the global obesity crisis intensifies, the functional aspect of brown adipose vs white adipose tissue
get in touch
Get the best insights about Cherry Biotech by Email
Let’s stay in touch!